Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Saiyu Tanaka, Takao Shirono, Yusuke Takahashi, Kento Takeuchi, Seita Kataoka, Michihisa Moriguchi, Takeshi Okanoue, et al. Prognostic performance of a two-step method using the Fibro-Scope system for metabolic dysfunction-associated steatotic liver disease. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Kento Takeuchi, Kanji Yamaguchi, Yusuke Takahashi, Kota Yano, Shinya Okishio, Hiroshi Ishiba, Nozomi Tochiki, Seita Kataoka, Hideki Fujii, Naoto Iwai, et al. Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction. Scientific reports. 2024. 14. 1. 23993-23993
Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, et al. Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver-Related Events in Metabolic Dysfunction-Associated Steatotic Liver Disease. Liver international : official journal of the International Association for the Study of the Liver. 2024
Ayana Fujiwara, Keisuke Takemura, Anna Tanaka, Misaki Matsumoto, Masato Katsuyama, Takeshi Okanoue, Kanji Yamaguchi, Yoshito Itoh, Kazumi Iwata, Kikuko Amagase, et al. Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation. Scientific reports. 2024. 14. 1. 19288-19288
Michihisa Moriguchi, Keiichiro Okuda, Go Horiguchi, Seita Kataoka, Yuya Seko, Kanji Yamaguchi, Takeshi Nishimura, Hideki Fujii, Yasuhide Mitsumoto, Masami Miyagawa, et al. Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver. 2024
